Vetter S, Weinberg J, Thomas BC, Kirchner M, Thalmann P, Klose C, Pfisterer M, Kölsch T, Oesterle S, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Link T, Bach P. Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial - ICONICplus Trial. BMJ Open. 2025 15(8):e106348.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Bach P, Koopmann A. Glucose intake reduces alcohol craving and amplifies habituation to cue-induced brain activation in male patients with alcohol use disorder: A randomized, placebo-controlled crossover study examining male and female patients with AUD. Psychoneuroendocrinology. 2025 177:107456.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Koopmann A, Bach P. Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response. Eur Addict Res. 2025 31(4):251-263.
Zimmermann US, Plickert C, Lüdecke C, Stuppe M, Rosenbeiger C, Krisam Y, Link T, Keller J, Bühler G, Scholz-Hehn D, Havemann-Reinecke U, Wedekind D, Luderer M, Spreer M. [Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"]. Nervenarzt. 2025 96(2):159-165.